Dove is developed by Conopco Inc. d/b/a/ Unilever.

What development phase is Dove in?

Dove is FDA-approved (marketed).

What is the generic name of Dove?

CERAMIDE is the generic (nonproprietary) name of Dove.

Last reviewed 2026-04-20 · How we verify

Dove (CERAMIDE)

Conopco Inc. d/b/a/ Unilever · FDA-approved active Small molecule Quality 6/100

At a glance

Generic name	CERAMIDE
Sponsor	Conopco Inc. d/b/a/ Unilever
Modality	Small molecule
Therapeutic area	Metabolic
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Sphingolipidomic Profile in Anorexia Nervosa
Skin Barrier Function and Inflammation in Aging: The BIA Study (PHASE4)
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer (PHASE1,PHASE2)
Ceramide Containing Multivesicular Emulsion Application . . . (NA)
Validation of Skin Instrumentation to Detect Ceramide-Driven Lipid Replenishment - Assessing Skin Glow, Hydration, Trans Epidermal Water Loss, Skin Surface Assessment, Sebum and Least-Reflection Factor. (NA)
Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (PHASE1)
Metronidazole SC Penetrance With Moisturizers (NA)
Evaluation of Serum Ceramides C16, C24, and Sphingosine-1-Phosphate (S1P) in Patients With Acne Vulgaris

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Dove CI brief — competitive landscape report
Dove updates RSS · CI watch RSS
Conopco Inc. d/b/a/ Unilever portfolio CI